Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Development of ligands for in vivo imaging of cerebral nicotinic receptors.

Sihver W, Nordberg A, Långström B, Mukhin AG, Koren AO, Kimes AS, London ED.

Behav Brain Res. 2000 Aug;113(1-2):143-57. Review.

PMID:
10942041
2.

Nicotinic acetylcholine receptors and imaging.

Gündisch D.

Curr Pharm Des. 2000 Jul;6(11):1143-57. Review.

PMID:
10903387
3.
4.

Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.

Newhouse PA, Kelton M.

Pharm Acta Helv. 2000 Mar;74(2-3):91-101. Review.

PMID:
10812945
5.

[Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].

Miyata H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2008 Aug;28(4):149-58. Review. Japanese.

PMID:
18800618
6.
7.

The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration.

O'Neill MJ, Murray TK, Lakics V, Visanji NP, Duty S.

Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):399-411. Review.

PMID:
12769612
8.

Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.

Iida Y, Ogawa M, Ueda M, Tominaga A, Kawashima H, Magata Y, Nishiyama S, Tsukada H, Mukai T, Saji H.

J Nucl Med. 2004 May;45(5):878-84.

9.
10.

Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors.

Saji H, Ogawa M, Ueda M, Iida Y, Magata Y, Tominaga A, Kawashima H, Kitamura Y, Nakagawa M, Kiyono Y, Mukai T.

Ann Nucl Med. 2002 May;16(3):189-200.

PMID:
12126044
11.

Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging.

Hellström-Lindahl E, Court JA.

Behav Brain Res. 2000 Aug;113(1-2):159-68.

PMID:
10942042
12.

Recent development of radioligands for imaging α7 nicotinic acetylcholine receptors in the brain.

Toyohara J, Wu J, Hashimoto K.

Curr Top Med Chem. 2010;10(15):1544-57. Review.

PMID:
20583992
13.

In vivo positron emission tomography studies on the novel nicotinic receptor agonist [11C]MPA compared with [11C]ABT-418 and (S)(-)[11C]nicotine in rhesus monkeys.

Sihver W, Fasth KJ, Ogren M, Lundqvist H, Bergström M, Watanabe Y, Långström B, Nordberg A.

Nucl Med Biol. 1999 Aug;26(6):633-40.

PMID:
10587101
14.

PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

Kadir A, Almkvist O, Wall A, Långström B, Nordberg A.

Psychopharmacology (Berl). 2006 Nov;188(4):509-20. Epub 2006 Jul 11.

PMID:
16832659
15.

Design and synthesis of new agents for neuronal nicotinic acetylcholine receptor (nAChRs) imaging.

Liu Y, Yu H, Zhao L, Zhang H.

Nucl Med Biol. 2013 Jan;40(1):126-34. doi: 10.1016/j.nucmedbio.2012.09.005. Epub 2012 Oct 26.

PMID:
23102538
16.

Synthesis and characterization of radioiodinated (S)-5-iodonicotine: a new ligand for potential imaging of brain nicotinic cholinergic receptors by single photon emission computed tomography.

Saji H, Watanabe A, Magata Y, Ohmomo Y, Kiyono Y, Yamada Y, Iida Y, Yonekura Y, Konishi J, Yokoyama A.

Chem Pharm Bull (Tokyo). 1997 Feb;45(2):284-90.

PMID:
9118442
17.
18.

Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.

Mihailescu S, Drucker-Colín R.

Arch Med Res. 2000 Mar-Apr;31(2):131-44. Review.

PMID:
10880717
19.

Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.

Xiao Y, Fan H, Musachio JL, Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ.

Mol Pharmacol. 2006 Oct;70(4):1454-60. Epub 2006 Jul 20.

20.

In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease.

Schmaljohann J, Gündisch D, Minnerop M, Bucerius J, Joe A, Reinhardt M, Guhlke S, Biersack HJ, Wüllner U.

Nucl Med Biol. 2006 Apr;33(3):305-9. Epub 2006 Mar 9.

PMID:
16631078
Items per page

Supplemental Content

Write to the Help Desk